RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXST is expected to report earnings to fall 764.33% to -19 cents per share on May 13
Q1'25
Est.
$-0.20
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.06
Q1'24
Beat
by $0.17
The last earnings report on February 25 showed earnings per share of 2 cents, beating the estimate of -17 cents. With 3.22M shares outstanding, the current market capitalization sits at 1.91B.